Dow Up0.24% Nasdaq Up0.43%

Northwest Biotherapeutics, Inc. (NWBO)

-NasdaqCM
5.46 Up 0.06(1.02%) 10:57AM EST - Nasdaq Real Time Price
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Total Revenue 809   772   10  
Cost of Revenue -   -   -  
Gross Profit 809   772   10  
Operating Expenses
Research Development43,906  28,908  13,452  
Selling General and Administrative12,364  15,675  13,335  
Non Recurring -   -   -  
Others12  14  10  
Total Operating Expenses -   -   -  
Operating Income or Loss (55,473) (43,825) (26,787)
Income from Continuing Operations
Total Other Income/Expenses Net(9,474)(10,053)1,605  
Earnings Before Interest And Taxes(64,947)(53,878)(25,182)
Interest Expense842  13,442  7,648  
Income Before Tax(65,789)(67,320)(32,830)
Income Tax Expense -   -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(65,789)(67,320)(32,830)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (65,789) (67,320) (32,830)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (65,789) (67,320) (32,830)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.